On the recordMay 1, 2023
In May of this year I joined with 24 my colleagues in both the Senate and the House asking for change at the FDA.
Source
congress.govEditor's note · Context
Rick Scott discusses a bipartisan request for FDA reform regarding rare disease therapies.
Share & report
More from Rick Scott
Jan 23, 2025
Mr. President, first, I want to thank my colleague from North Carolina for his comments with regard to Canada, Greenland, Mexico, and the Panama Canal. We have to support the President. He is acting in the best interests of the American…
Sep 24, 2024
I further ask that the bill be considered read a third time and passed and that the motion to reconsider be considered made and laid upon the table with no intervening action or debate. The PRESIDING OFFICER. Without objection, it is so…
Other voices in this conversation
